Literature DB >> 30028267

Multipotent mesenchymal stromal cell-derived exosomes improve functional recovery after experimental intracerebral hemorrhage in the rat.

Yuxia Han1, Don Seyfried2, Yuling Meng1, Dongmei Yang1, Lonni Schultz3, Michael Chopp2, Donald Seyfried1.   

Abstract

OBJECTIVE: Previous studies have demonstrated that transplanted multipotent mesenchymal stromal cells (MSCs) improve functional recovery in rats after experimental intracerebral hemorrhage (ICH). In this study the authors tested the hypothesis that administration of multipotent MSC-derived exosomes promotes functional recovery, neurovascular remodeling, and neurogenesis in a rat model of ICH.
METHODS: Sixteen adult male Wistar rats were subjected to ICH via blood injection into the striatum, followed 24 hours later by tail vein injection of 100 μg protein of MSC-derived exosomes (treatment group, 8 rats) or an equal volume of vehicle (control group, 8 rats); an additional 8 rats that had identical surgery without blood infusion were used as a sham group. The modified Morris water maze (mMWM), modified Neurological Severity Score (mNSS), and social odor-based novelty recognition tests were performed to evaluate cognitive and sensorimotor functional recovery after ICH. All 24 animals were killed 28 days after ICH or sham procedure. Histopathological and immunohistochemical analyses were performed for measurements of lesion volume and neurovascular and white matter remodeling.
RESULTS: Compared with the saline-treated controls, exosome-treated ICH rats showed significant improvement in the neurological function of spatial learning and motor recovery measured at 26-28 days by mMWM and starting at day 14 by mNSS (p < 0.05). Senorimotor functional improvement was measured by a social odor-based novelty recognition test (p < 0.05). Exosome treatment significantly increased newly generated endothelial cells in the hemorrhagic boundary zone, neuroblasts and mature neurons in the subventricular zone, and myelin in the striatum without altering the lesion volume.
CONCLUSIONS: MSC-derived exosomes effectively improve functional recovery after ICH, possibly by promoting endogenous angiogenesis and neurogenesis in rats after ICH. Thus, cell-free, MSC-derived exosomes may be a novel therapy for ICH.

Entities:  

Keywords:  ANOVA = analysis of variance; BBB = blood-brain barrier; ICH = intracerebral hemorrhage; MSC = mesenchymal stromal cell; OPC = oligodendrocyte progenitor cell; PBS = phosphate-buffered saline; SE = standard error; SVZ = subventricular zone; TBI = traumatic brain injury; angiogenesis; exosomes; experimental intracerebral hemorrhage; functional recovery; mMWM = modified Morris water maze; mNSS = modified Neurological Severity Score; mesenchymal stromal cell; neurogenesis

Year:  2018        PMID: 30028267     DOI: 10.3171/2018.2.JNS171475

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  26 in total

Review 1.  Efficacy of stem cell secretome in the treatment of traumatic brain injury: A systematic review and meta-analysis of preclinical studies.

Authors:  Suleiman Alhaji Muhammad; Abdullahi Yahya Abbas; Mustapha Umar Imam; Yusuf Saidu; Lawal Suleiman Bilbis
Journal:  Mol Neurobiol       Date:  2022-03-01       Impact factor: 5.590

2.  Mechanisms of memory impairment in animal models of nontraumatic intracranial hemorrhage: A systematic review of the literature.

Authors:  Catherine Peterson; Alexis O Umoye; Chloe H Puglisi; Ben Waldau
Journal:  Brain Hemorrhages       Date:  2021-08-10

Review 3.  Application of stem cells and exosomes in the treatment of intracerebral hemorrhage: an update.

Authors:  Jian-Feng Zhou; Yu Xiong; Xiaodong Kang; Zhigang Pan; Qiangbin Zhu; Roland Goldbrunner; Lampis Stavrinou; Shu Lin; Weipeng Hu; Feng Zheng; Pantelis Stavrinou
Journal:  Stem Cell Res Ther       Date:  2022-06-28       Impact factor: 8.079

4.  Momordica charantia Exosome-Like Nanoparticles Exert Neuroprotective Effects Against Ischemic Brain Injury via Inhibiting Matrix Metalloproteinase 9 and Activating the AKT/GSK3β Signaling Pathway.

Authors:  Heng Cai; Lin-Yan Huang; Rui Hong; Jin-Xiu Song; Xin-Jian Guo; Wei Zhou; Zhao-Li Hu; Wan Wang; Yan-Ling Wang; Jian-Gang Shen; Su-Hua Qi
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

5.  Mesenchymal derived exosomes enhance recovery of motor function in a monkey model of cortical injury.

Authors:  T L Moore; B G E Bowley; M A Pessina; S M Calderazzo; M Medalla; V Go; Z G Zhang; M Chopp; S Finklestein; A G Harbaugh; D L Rosene; B Buller
Journal:  Restor Neurol Neurosci       Date:  2019       Impact factor: 2.406

6.  Extracellular vesicles derived from bone marrow mesenchymal stem cells alleviate neuroinflammation after diabetic intracerebral hemorrhage via the miR-183-5p/PDCD4/NLRP3 pathway.

Authors:  H Ding; Y Jia; H Lv; W Chang; F Liu; D Wang
Journal:  J Endocrinol Invest       Date:  2021-05-23       Impact factor: 4.256

Review 7.  Long Non-coding RNA in CNS Injuries: A New Target for Therapeutic Intervention.

Authors:  Li Zhang; Handong Wang
Journal:  Mol Ther Nucleic Acids       Date:  2019-07-29       Impact factor: 8.886

Review 8.  Progress of Research on Exosomes in the Protection Against Ischemic Brain Injury.

Authors:  Xianhui Kang; Ziyi Zuo; Wandong Hong; Hongli Tang; Wujun Geng
Journal:  Front Neurosci       Date:  2019-10-29       Impact factor: 4.677

Review 9.  The spleen may be an important target of stem cell therapy for stroke.

Authors:  Zhe Wang; Da He; Ya-Yue Zeng; Li Zhu; Chao Yang; Yong-Juan Lu; Jie-Qiong Huang; Xiao-Yan Cheng; Xiang-Hong Huang; Xiao-Jun Tan
Journal:  J Neuroinflammation       Date:  2019-01-30       Impact factor: 8.322

Review 10.  Brain Derived Exosomes Are a Double-Edged Sword in Alzheimer's Disease.

Authors:  Zhiqi Song; Yanfeng Xu; Wei Deng; Ling Zhang; Hua Zhu; Pin Yu; Yajin Qu; Wenjie Zhao; Yunlin Han; Chuan Qin
Journal:  Front Mol Neurosci       Date:  2020-05-29       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.